Tutorials › Statistical Genetics › Diagnosing Discordant Individual-Level And Summary Estimates

Genetic Correlation Across Traits · Tutorial 574 of 989

Diagnosing Discordant Individual-Level And Summary Estimates

Learn to distinguish genuine estimator disagreement from differences in the genetic quantities each method measures, then investigate the most likely sources systematically.

Advanced 11 min read

What You'll Learn

  • Define the genetic-correlation estimands targeted by mixed models and cross-trait LD score regression
  • Compare point estimates and uncertainty without treating them as interchangeable
  • Diagnose discrepancies related to sample overlap, ancestry, phenotype definitions, and variant coverage
  • Check how model assumptions and analysis choices can alter an estimate
  • Organize follow-up analyses to identify which differences are consequential

Why Two Valid Estimates Can Disagree

Individual-level genomic mixed models and cross-trait LD score regression (LDSC) use different data and different sources of information. A mixed model uses phenotypes and a genetic relationship matrix to estimate covariance among traits associated with genomic similarity between individuals. Cross-trait LDSC uses genome-wide summary statistics and linkage disequilibrium patterns to estimate covariance attributable to common variants. Thus, disagreement is not automatically evidence that one analysis is wrong. First ask whether the analyses target the same genetic quantity in comparable populations, on comparable trait scales, and with sufficiently compatible assumptions.

This tutorial focuses on diagnosing such disagreements. It does not treat a numerical difference alone as a test of which method is correct: formal comparison requires the uncertainty of both estimates and their dependence, which can be substantial when analyses share participants or data.

Definition: A genetic correlation is a standardized genetic covariance. For a specified genetic component and target population, \(r_g=\sigma_{g,12}/\sqrt{\sigma_{g,1}^2\sigma_{g,2}^2}\), where \(\sigma_{g,12}\) is the genetic covariance between traits 1 and 2, and \(\sigma_{g,1}^2\) and \(\sigma_{g,2}^2\) are their genetic variances. The correlation is defined when both variances are positive. Its value depends on which genetic component, variants, population, and trait scales define those quantities.

What the Two Approaches Estimate

In an individual-level bivariate genomic mixed model, the observed phenotypes are modeled using fixed effects and random genetic effects. In a simplified form, let \(y_1\) and \(y_2\) be phenotype vectors for the two traits, and let \(K\) be a genomic relationship matrix constructed from measured variants. The additive genetic effects are modeled jointly, with covariance linked to \(K\):

$$ \begin{pmatrix} g_1 \\ g_2 \end{pmatrix} \sim N\left( \begin{pmatrix} 0 \\ 0 \end{pmatrix}, \begin{pmatrix} \sigma_{g,1}^2 & \sigma_{g,12}\\ \sigma_{g,12} & \sigma_{g,2}^2 \end{pmatrix} \otimes K \right). $$

Here \(g_1\) and \(g_2\) are vectors of genetic effects for the analyzed individuals. The model also requires an appropriate residual covariance structure and fixed-effect specification. Restricted maximum likelihood estimates the variance components under the fitted model, and their standardized covariance gives the model-based estimate of \(r_g\). Its interpretation depends on the relationship matrix, included variants, sample, phenotype definitions, covariates, and assumptions about the genetic and residual effects.

Cross-trait LDSC instead relates products of association \(Z\)-statistics across variants to their LD scores. The fitted slope provides an estimate of genetic covariance attributable to the variant set and LD reference represented by the analysis; the intercept accounts for a component not explained by LD scores, including certain effects of sample overlap and confounding. Combining the covariance estimate with compatible single-trait genetic-variance estimates yields an LDSC genetic correlation. These are summary-statistic estimates, not individual-level estimates from the same likelihood.

The comparison is most interpretable when both analyses refer to similar populations, phenotype scales, covariate adjustments, and genetic variation. Even then, the estimates need not match exactly: the two approaches have different sampling variability, model assumptions, and sensitivity to how genetic information is represented.

Compare Estimates Before Explaining Them

Record each estimate together with its standard error, confidence interval, sample size, ancestry composition, phenotype definition, and variant set. A point-estimate difference can be large relative to one method’s uncertainty and small relative to the other’s. Conversely, broad intervals can leave substantial uncertainty even when the point estimates look similar.

For a rough descriptive comparison, calculate the signed difference and state its direction. Do not call that difference statistically significant using the standard errors as if the estimates were independent unless independence is justified. If both methods use overlapping participants or related inputs, the covariance between estimates may be nonzero. The variance of their difference is

$$ \operatorname{Var}(\hat r_{g,A}-\hat r_{g,B}) = \operatorname{Var}(\hat r_{g,A})+\operatorname{Var}(\hat r_{g,B}) -2\operatorname{Cov}(\hat r_{g,A},\hat r_{g,B}). $$

Without the covariance term, a formal standard error or test for the difference is not established. Confidence-interval overlap can provide context, but it is not itself a test of equality.

Worked Example: A Difference With Substantial Uncertainty

Suppose a hypothetical mixed-model analysis estimates \(r_g=0.42\) with \(SE=0.12\), while a hypothetical cross-trait LDSC analysis estimates \(r_g=0.08\) with \(SE=0.09\). For orientation, form approximate 95% intervals using estimate \(\pm 1.96SE\).

For the mixed model, \(0.42\pm1.96(0.12)=0.42\pm0.2352\), giving an interval from \(0.1848\) to \(0.6552\). For LDSC, \(0.08\pm1.96(0.09)=0.08\pm0.1764\), giving an interval from \(-0.0964\) to \(0.2564\).

The signed difference is \(0.42-0.08=0.34\). The intervals overlap between \(0.1848\) and \(0.2564\), but that overlap does not establish that the methods agree. Nor can the difference be assigned a valid test statistic from the two standard errors alone: the covariance of the estimates is not supplied, and could matter if the analyses share participants or other inputs. The appropriate conclusion is that the point estimates differ by 0.34, while the uncertainty and dependence information are insufficient here for a formal test of that difference.

Diagnose the Target Before the Data

A useful first check is whether the two estimates describe the same target. A mixed model’s genetic covariance is defined relative to its relationship matrix and modeled genetic effects. LDSC’s estimate reflects the common-variant signal captured through its summary statistics and LD reference. Differences in variant coverage or allele-frequency distributions can therefore change the genetic component each method captures. A correlation is standardized, but standardization does not make estimates from different components or populations interchangeable.

Trait definitions and scales also matter. “Diagnosed disease,” “self-reported disease,” and a quantitative risk score are not automatically the same phenotype. Transformations can change the scale on which covariance and variances are expressed, and consequently can change the reported genetic correlation. For binary traits, confirm whether estimates are on the observed scale or have been transformed to a liability scale, and check that any transformations are compatible across analyses.

Ancestry and study composition deserve explicit attention. Allele frequencies, LD patterns, environmental exposures, ascertainment, and trait measurement can vary across populations. Mixed-model and LDSC estimates from different ancestry compositions may target different genetic relationships, even if the trait labels match. A discrepancy should not be attributed to ancestry solely because ancestry differs; rather, ancestry differences identify a plausible source to investigate, ideally with analyses on comparable samples and well-matched variant sets.

Worked Example: Separating an Ancestry Difference From Method Difference

Consider hypothetical analyses of two traits. The individual-level mixed model uses 18,000 participants from one ancestry group and estimates \(r_g=0.36\) with \(SE=0.10\). The LDSC analysis uses summary statistics from a larger, multi-ancestry sample and estimates \(r_g=0.11\) with \(SE=0.07\). The point-estimate difference is \(0.36-0.11=0.25\).

The difference cannot be attributed to the statistical methods alone: the population composition differs as well. A useful diagnostic is to rerun or restrict analyses to a comparable ancestry group, using harmonized traits and overlapping variant coverage where feasible. Suppose, hypothetically, that an ancestry-matched LDSC analysis then estimates \(r_g=0.30\) with \(SE=0.09\). The change from \(0.11\) to \(0.30\) indicates that sample composition or analysis inputs may have contributed to the original discrepancy. It does not prove that ancestry was the only cause: restriction changes sample size and precision, and other design differences may remain.

The original comparison therefore supports a diagnostic conclusion, not a causal one: the two analyses differ both in method and target population, so their estimates should not be treated as a clean head-to-head comparison.

Check Overlap, Phenotypes, Variants, and Assumptions

Sample overlap can affect both interpretation and uncertainty. In cross-trait LDSC, correlated sampling errors caused by overlapping participants can contribute to the cross-trait intercept. This adjustment does not make arbitrary overlap harmless: the intercept, sample sizes, and the assumptions of the regression must still be appropriate. In an individual-level model, using the same individuals for both traits is a different data structure from using separate samples, and the residual covariance and missingness pattern must be modeled appropriately. When analyses use shared data, their resulting estimates are also generally not independent.

Phenotype checks should establish that case definitions, controls, measurement instruments, covariate adjustments, age ranges, and transformations are as comparable as possible. Differences in case ascertainment or control selection can change the statistical phenotype even when both analyses use the same diagnostic label. Verify that summary-statistic alleles are harmonized and that the individual-level relationship matrix and LDSC analysis use compatible sets of well-measured variants. Variant coverage matters because the two methods need not capture identical genetic effects.

Finally, assess the assumptions behind each fitted model. The mixed model depends on a suitable relationship matrix, a valid specification of fixed effects and residual covariance, and adequate control of population structure and relatedness effects. LDSC depends on suitable LD scores and reference information, reliable summary statistics, and the regression assumptions used to separate the LD-dependent signal from the intercept. A failed assumption can shift an estimate or make its uncertainty unreliable; merely obtaining a numerical answer does not verify the model.

Justification: A change in the genetic correlation need not mean the genetic covariance changed. For example, suppose \(\sigma_{g,12}=0.24\), \(\sigma_{g,1}^2=0.36\), and \(\sigma_{g,2}^2=0.64\). Then \(r_g=0.24/\sqrt{0.36(0.64)}=0.24/0.48=0.50\). If the covariance remains \(0.24\), but the first genetic variance is \(0.49\), then \(r_g=0.24/\sqrt{0.49(0.64)}=0.24/0.56\approx0.429\). Thus, differences in the variance estimates or in the genetic component represented can change the standardized correlation even when the covariance is unchanged.

Worked Example: Variant Coverage as a Diagnostic

Suppose a hypothetical mixed model uses a broad set of common and less-common measured variants and estimates \(r_g=0.48\) with \(SE=0.11\). A cross-trait LDSC analysis using a common-variant reference estimates \(r_g=0.19\) with \(SE=0.08\). The difference is \(0.48-0.19=0.29\). The two estimates may not represent the same genetic component, so the gap is not by itself evidence of bias.

The analyst checks variant quality control, allele harmonization, LD reference ancestry, and the variants contributing to each method. A useful sensitivity analysis is to restrict the individual-level relationship matrix to a well-matched common-variant set, then refit the model. Suppose that estimate is \(0.27\) with \(SE=0.12\). The shift from \(0.48\) to \(0.27\) is consistent with variant coverage contributing to the original discrepancy, but does not isolate its effect: changing the variant set can also alter precision and the fitted variance components. The remaining difference from \(0.19\) should prompt checks of phenotype comparability, samples, and model assumptions rather than an automatic claim that the methods now agree.

A Practical Diagnostic Sequence

Keep the investigation ordered. Start with the target and data before tuning models or interpreting biological explanations.

1
Align the estimands.
Write down the genetic component, target population, variant set, phenotype scale, and transformations for each estimate. Mark any mismatch explicitly.
2
Verify samples and inputs.
Check ancestry composition, sample overlap, case and control definitions, missingness, allele harmonization, LD reference, and variant quality control.
3
Review model diagnostics.
Inspect mixed-model convergence and covariance estimates, and review LDSC regression behavior, intercept, and standard errors. Confirm that the specified covariates and assumptions are defensible.
4
Run targeted sensitivity analyses.
Change one consequential feature at a time where possible, such as restricting to a matched ancestry or variant set. Report how both the estimate and uncertainty respond.
5
State what remains unresolved.
Distinguish a demonstrated input difference from a plausible explanation. Do not declare one method correct based only on a closer point estimate or overlapping intervals.

Common Mistake and Why the Comparison Matters

Wrong reasoning: “The mixed-model estimate is larger, so LDSC must be biased downward.” This treats the estimates as measurements of one identical quantity and assumes their difference has only one possible explanation. It ignores differences in samples, variant coverage, phenotype scale, model assumptions, and uncertainty.

Correction: First determine whether the estimates target comparable genetic correlations. Then investigate design and input differences, model diagnostics, and sensitivity to harmonized choices. Report estimates with uncertainty and describe the limits of any comparison. If the methods use overlapping participants, do not test their difference as though the estimates were independent unless their covariance has been accounted for.

Careful diagnosis matters because genetic correlations are often used to summarize shared genetic architecture across traits. A discrepancy may reflect different genetic components or populations rather than a contradiction about biology. Equally, apparent agreement does not guarantee valid estimation: two analyses can agree while sharing a phenotype mismatch or an unexamined assumption.

Check Your Understanding

Answer each question by identifying what the estimates do and do not establish.

  1. Why does a mixed-model genetic correlation based on one relationship matrix not necessarily estimate exactly the same quantity as cross-trait LDSC?
  2. Two methods share participants, and their point estimates differ. What additional information is needed for a formal test of the difference?
  3. Name two ways that non-comparable phenotype definitions or scales can contribute to discordant estimates.
  4. Why can ancestry differences be a diagnostic concern without proving that ancestry caused a discrepancy?
  5. If restricting an individual-level analysis to a common-variant set moves its estimate toward the LDSC estimate, what is a cautious interpretation of that result?
Clinical Biostats